Loading...
Symbols:
Loading...
Symbols:
Trimeris, Inc. (TRMS)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Trimeris, Inc. (TRMS)
12 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on TRMS
- Centient Biotech Investor(3)
- Zacks.com (2)
- David Tsao (2)
- TickerSense (1)
- SA Editor Jonathan Liss(1)
Most popular authors
(tracked in watchlists)
- Andrew Wilkinson(334)
- Zacks.com (127)
- Notable Calls(112)
- TickerSense (43)
- Lon Juricic(15)
Most commented on authors
- Centient Biotech Investor(2)
- Zacks.com (2)
- Andrew Wilkinson(1)
- TickerSense (0)
- SA Editor Jonathan Liss(0)
- Biotech Outlook: M&A Will Continue
- BioMarin, Myriad, and Regeneron Show a Quiet Strength
- Monday Options Outlook: XLE, YHOO, TGT, TRMS, BGP, STI, ECL, GES, PVH
- Trimeris' Change in COGS Calculations Raises Concerns
- Holding on to My Trimeris Stake for Now
- Large Trimeris Holder Requests Meeting With Management
- Roche/Trimeris Report Positive Interim Fuzeon Results
- Expecting Trimeris To Fall Following HIV Drug Development
- Biotech In Review: Bidding War Erupts For Biosite
- Russell 3000's Best and Worst Stocks, Week and Year to Date
- Biotech In Review: Adams Respiratory Guides Lower
- Biotech Day in Review: Hopeful Results from HIV Conference
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »